Nano-Tacrolimus

N/A

Report date: 2026/03/04 20:01:44

Base Information

Drug NameNano-Tacrolimus
Drug Alias NameNano-Tactacrolimustacrolimus ophthalmic drops (BioNanoSim)tacrolimus (BioNanoSim)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCalcineurin inhibitors
TargetsCalcineurin
Therapy Area/IndicationsOcular inflammationUveitis, IntermediateUveitis +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesIsrael
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesBioNanoSim Ltd
China Registration ClassN/A

Develop Information

Active CompaniesBioNanoSim Ltd
Inactive CompaniesN/A
Active IndicationsOcular inflammationUveitis, IntermediateUveitis +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A